Serum Dioxin, Testosterone, and Subsequent Risk of Benign Prostatic Hyperplasia: A Prospective Cohort Study of Air Force Veterans
2006

Dioxin Exposure and Risk of Benign Prostatic Hyperplasia in Veterans

Sample size: 2237 publication 10 minutes Evidence: moderate

Author Information

Author(s): Amit Gupta, Norma Ketchum, Claus G. Roehrborn, Arnold Schecter, Corinne C. Aragaki, Joel E. Michalek

Primary Institution: The University of Texas Southwestern Medical Center at Dallas

Hypothesis

Does higher serum TCDD exposure lead to a lower risk of being diagnosed with benign prostatic hyperplasia (BPH)?

Conclusion

Higher TCDD exposure is associated with a decreased risk of BPH, but may increase at higher exposure levels.

Supporting Evidence

  • The risk of BPH decreased with increasing serum TCDD in the comparison group.
  • Serum testosterone levels were inversely associated with serum TCDD levels.
  • The study had a large sample size compared to previous studies on the same hypothesis.

Takeaway

Veterans exposed to more dioxins had a lower chance of developing prostate problems, but too much exposure might be bad.

Methodology

This was a longitudinal, prospective cohort study involving U.S. Air Force veterans, comparing those exposed to TCDD with those who were not.

Potential Biases

Potential misclassification of BPH diagnosis due to reliance on medical records.

Limitations

The study only measured TCDD levels and did not account for other dioxin-like compounds; the population was predominantly white, limiting generalizability.

Participant Demographics

The study included U.S. Air Force veterans, predominantly white males.

Statistical Information

P-Value

0.02

Confidence Interval

0.73–0.98

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1289/ehp.8957

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication